Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
55,569,423
-
Share change
-
-640,246
-
Total reported value
-
$354,536,417
-
Price per share
-
$6.38
-
Number of holders
-
104
-
Value change
-
-$3,693,258
-
Number of buys
-
51
-
Number of sells
-
30
Institutional Holders of GENMARK DIAGNOSTICS INC - COM (GNMK) as of Q2 2018
As of 30 Jun 2018,
GENMARK DIAGNOSTICS INC - COM (GNMK) was held by
104 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,569,423 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, CADIAN CAPITAL MANAGEMENT, LP, JPMORGAN CHASE & CO, PUTNAM INVESTMENTS LLC, Casdin Capital, LLC, BlackRock Inc., VANGUARD GROUP INC, HighTower Advisors, LLC, and Alyeska Investment Group, L.P..
This page lists
104
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.